Anti-HLA-DR 抗体 [TAL 1B5]
Anti-HLA-DR antibody [TAL 1B5]
- Recombinant
- Lab Essentials
- 了解详情
5
(6 Reviews)
|
(67 Publications)
Anti-HLA-DR antibody [TAL 1B5] (ab20181) is a mouse monoclonal antibody detecting HLA-DR in Western Blot, Flow Cytometry, IHC-P, ICC/IF. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
- Over 50 publications
- Trusted since 2005
查看别名
HLA-DRA1, HLA-DRA, MHC class II antigen DRA
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
Immunohistochemical analysis of paraffin-embedded human skin tissue labeling HLA-DR with ab20181 at 0.1 μg/ml followed by Leica DS9800 (Bond™ Polymer Refine Detection). The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab20181, 0.1ug/ml, for 15 mins at room temperature and was then detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling HLA-DR with ab20181 at 0.1 μg/ml followed by Leica DS9800 (Bond™ Polymer Refine Detection). The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab20181, 0.1ug/ml, for 15 mins at room temperature and was then detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
- Flow Cyt
Lab
Flow Cytometry - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) with ab20181 (right) or mouse IgG1κ (ab170190) isotype (left). PBMCs were incubated for 30 min on ice in 1x PBS containing 10μg/ml human IgG and 10% normal goat serum to block FC receptors and non-specific protein-protein interaction followed by followed by staining with CD19 APC. PBMCs were then fixed in 4.2% formaldehyde and permeabilised in 0.1% saponin before staining with the antibody (ab20181) or mouse IgG1κ (ab170190) isotype (1x106 in 100μl; at 0.008μg/ml) for 30 min on ice. The secondary antibody Goat anti-mouse IgG H&L (Alexa Fluor ® 488, pre-adsorbed) (ab150117) was used at 1 : 2000 dilution for 30 min on ice. Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on alive lymphocytes.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
ab20181 staining HLA DR in Raji cells. The cells were fixed with 4% formaldehyde (10 min), permeabilised in 0.1% Triton X-100 for 5 minutes and then blocked in 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab20181 at 1/1000 dilution and ab7291, Mouse monoclonal to alpha Tubulin at 1/1000 dilution. Cells were then incubated with ab150119, Goat Anti-Mouse IgG H&L (Alexa Fluor® 647) preadsorbed, at 1/1000 dilution (shown in red) and ab150081, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488), preadsorbed at 1/1000 dilution (shown in green). Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling HLA-DR with ab20181 at a concentration of 0.01µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
ab20181 Anti-HLA-DR antibody [TAL 1B5] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- WB
AbReview28146****
Western blot - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
This image was generated from a previous batch made using the hybridoma production method.
All lanes:
Western blot - Anti-HLA-DR antibody [TAL 1B5] (ab20181) at 0.667 µg/mL
All lanes:
whole tissue lysate prepared from human colon at 50 µg
Secondary
All lanes:
HRP conjugated goat anti-mouse polyclonal at 1/3000 dilution
Predicted band size: 29 kDa
Observed band size: 33 kDa
true
Exposure time: 5s
Image courtesy of an anonymous Abreview.
- WB
Lab
Western blot - Anti-HLA-DR antibody [TAL 1B5] (AB20181)
Lanes 1-3 : Merged signal (red and green). Green - ab20181 observed at 35 kDa. Red - loading control ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) observed at 37 kDa. ab20181 was shown to react with HLA-DR in Western blot. Membranes were blocked with 3% milk in TBS-T (0.1% Tween®) before incubation with ab20181 and ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) overnight at 4°C at 1 µg/ml and a 1 : 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 : 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-HLA-DR antibody [TAL 1B5] (ab20181) at 1/1000 dilution
Lane 1:
Raji whole cell lysate at 20 µg
Lane 2:
Daudi whole cell lysate at 20 µg
Lane 3:
HEK-293 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Observed band size: 35 kDa
true
反应性数据
产品详情
Anti-HLA-DR antibody [TAL 1B5] (ab20181) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt, ICC/IF, IHC-P, WB in human samples.
Anti-HLA-DR antibody [TAL 1B5] (ab20181) has been cited over 51 times in peer reviewed journals and is trusted by the scientific community.
Abcams high quality manufacturing and validation processes ensure Anti-HLA-DR antibody [TAL 1B5] (ab20181) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-HLA-DR antibody [TAL 1B5] (ab20181) has 6 independent reviews from customers.
Anti-HLA-DR antibody [TAL 1B5] (ab20181) specifically detects HLA-DR (UniProt ID: P01903; Molecular weight: 26kDa) and is sold in 100 ug 1 mg selling sizes.
Conjugation-ready, carrier free format available for antibody clone TAL 1B5 - ab17648.
Antibody clone TAL 1B5 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Alexa Fluor® 488, Alexa Fluor® 555, FITC (ab22397, ab39369, ab3956, ab31774).
HLA-DR is a major histocompatibility complex (MHC) class II receptor involved in presenting antigens to T cells, playing a crucial role in the immune response to tumors. High HLA-DR expression on tumor-infiltrating lymphocytes is associated with better clinical outcomes in certain cancers.
This product has switched from a hybridoma to recombinant production method on 23 September 2022.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (67)
Recent publications for all applications. Explore the full list and refine your search
Renal failure 47:2537797 PubMed40775738
2025
Applications
Unspecified application
Species
Unspecified reactive species
NPJ breast cancer 11:72 PubMed40675997
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical cancer research : an official journal of the American Association for Cancer Research 30:4601-4608 PubMed39167623
2024
Applications
Unspecified application
Species
Unspecified reactive species
Arthritis research & therapy 26:144 PubMed39080801
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:4698 PubMed38844770
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 42:396-412.e5 PubMed38242124
2024
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 120:e2305756120 PubMed37722062
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107585 PubMed37694144
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 14:1182180 PubMed37545539
2023
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 8: PubMed37252795
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com